European equities traded in the US as American depositary receipts kicked off the week moderately higher late Monday morning, rising 0.84% to 1,395.97 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and internet browser company Opera (OPRA), which rose 6.9% and 4.3%, respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Genfit (GNFT), which were up 4.2% and 3.9%, respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS), which lost 4.6%, and furniture maker Natuzzi (NTZ), which retreated 3.6%. They were followed by internet advertising firm Criteo (CRTO) and telecommunications firm Nokia (NOK), which were down 3% and 0.8%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and cruise line operator Carnival (CUK), which increased 4.3% and 2.7%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and NuCana (NCNA), which advanced 2.4% and 2.3%, respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which fell 3.8% and 1.3% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which were off 0.4% and 0.3% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。